DOWNLOAD PRODUCT PROFILE

• Unimark Remedies Ltd., is a manufacturing company which provides affordable generic APIs for local and global markets.
• The company has a manufacturing record of more than 18 years and has been approved, inspected and audited by US FDA, EU-GMP and other regulatory bodies on over 6 occasions.
• The company has been recently acquired by SHAMROCK PHARMA GROUP and is now 100% owned by them. The new management brings in more accountability, commitment and better upgraded facilities to meet the high quality and regulatory requirements of global markets.
• It has state-of-the-art facilities, latest technological capabilities and has optimized the chemical processes for all its APIs.
• The state-of-the-art facility is designed to cater to all regulated markets including USA. EU, CANADA and RoW.
• The company’s API facilities are approved by USFDA, EDQM, TGA, UK MHRA and WHO, it’s a fully compliant cGMP facility.

• Dedicated Carbapenem facility
• Leading developer of Carbapenems at USFDA compliant facility
• In-house production of Intermediates & Side Chains (No dependency on imports)
• Dedicated facility for Orals Sterile / APIs / FDF – Carbapenems
• Largest Integrated Plant from Chemical to Vials (Sterile)
• Dedicated R&D for Carbapenems ◦ USFDA / EUGMP / PMDA / KFDA / MHRA / TGA Compliant
• 16 DMFS (Technical & Sterile) for Carbapenems

Download the entire Marketing Collateral